期刊文献+

栓塞化疗联合无水酒精治疗中晚期原发性肝癌合并门静脉癌栓78例疗效观察 被引量:2

Effects observation of 78 patients with advanced hepatocellar carcinoma with portal vein tumor thrombus treated with ethanol injection and chemoembolization
在线阅读 下载PDF
导出
摘要 目的观察无水酒精注射术治疗中晚期原发性肝癌(PHC)合并门静脉癌栓(PVTT)的临床疗效。方法 78例合并门静脉癌栓的中晚期肝癌均在选择性肝动脉化疗栓塞(TACE)的基础上加门静脉癌栓内无水酒精注射术(PEI),观察治疗效果。结果 TACE加门静脉癌栓PEI后3年生存率为29.5%;治疗后门静脉癌栓总有效率为71.8%(56/78)。治疗前后患者肿瘤大小及血中AFP水平,差异有统计学意义(P<0.05),无严重并发症。结论 TACE加PEI治疗中晚期肝癌合并门静脉癌栓患者是一种有效的方法。 Objective To observe the effect of alcohol injection in the treatment of advanced hepatocellar carcinoma with portal vein tumor thrombus.Methods Seventy-eight patients in advanced hepatocellar carcinoma with portal vein tumor thrombus were selected to treatment with hepatic artery chemoembolization (TACE) and alcohol injection in portal vein tumor thrombus.And the effect of all the patients after treatment were observed.Results The survival rate of patients after 3 years treatment was 29.5%,the total effective rate of portal vein tumor thrombus was 71.8%(56/78),the shorten mass and level of decreasing AFP between pre-and pos-treatment were significantly different (P 0.05),and ingand no serious complications.Conclusion TACE plus PEI has an effective treatment in advanced hepatocellar carcinoma with portal vein tumor thrombus.
出处 《中国当代医药》 2012年第33期162-163,共2页 China Modern Medicine
关键词 肝癌 门静脉癌栓 无水酒精注射 疗效观察 Hepatocellar carcinoma Portal vein tumor thrombus Alcohol injection Effects observation
  • 相关文献

参考文献6

二级参考文献29

  • 1Jia Fan,Zhi Quan Wu,Zhao You Tang,Jian Zhou,Shuang Jian Qiu,Zeng Chen Ma,Xin Da Zhou,Sheng Long Ye Liver Cancer Institute, Zhongshan Hospital, Hehai University Medical Center (Former Shanghai University), 136 Yixueyuan Road, Shanghai 200032, China.Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein[J].World Journal of Gastroenterology,2001,7(1):28-32. 被引量:80
  • 2余业勤,徐东波,郑亚新,张博恒.肝癌切除联同门静脉癌栓取出术治疗肝癌(附25例报告)[J].中国实用外科杂志,1994,14(1):18-19. 被引量:22
  • 3梅铭惠,王军,陈谦,张显岚,杨景红,徐静,卢方,邓伟.门静脉癌栓所致急性门脉高压症的诊治[J].腹部外科,1995,8(2):68-69. 被引量:1
  • 4陆正华,沈锋.门静脉癌栓研究进展[J].中国微创外科杂志,2007,7(1):64-66. 被引量:6
  • 5Minagawa M, Makuuclai M, Takayama T, et al. Selection criteria for hepatectomary in patients with hepatocellular carcinorn and portal vein tumor thrornbus[ J]. Ann Surg ,2001,233:279 - 384.
  • 6Asaki Y, Imaoka S, Kasugai H, et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplafin, and gelatin sponge[J]. Cancer,1987,60(6) :1194- 1203.
  • 7Chung JW, Park JH, Han JK, et al. Hepatocellular carcinoma and portal vein invasion : results of treatment with transcatheter oil chemoembolization [ J ]. Am J Radiol, 1995,165 (2) :315 - 321.
  • 8Katsumori T, Fujita M, Satoh.O, et al. Effective segmental chempembolization of advanced bepatocellular carcinoma with tumor thrombus in the portal vein [ J ]. Cardiovase Intervent Radiol, 1995,18(4) :217 -221.
  • 9梅铭惠,陈谦,张显岚,杨景红,徐静卢,方邓伟.肝门部外科解剖技巧与要点[J].广西科学,1997,4(1):61-63. 被引量:11
  • 10Barbro Linderholm,Eva Karlsson,Sigrid Klaar,Thomas Lindahl,Anna-Lena Borg,G?ran Elmberger,Jonas Bergh.Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers[J].European Journal of Cancer.2004(16)

共引文献20

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部